Motus GI Holdings Inc. (MOTS)
NASDAQ (CM) NASDAQ (CM) Primary Summary
Motus GI Holdings Inc. Analysts
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| YC Yi Chen HC Wainwright & Co. | -344,598.41 | $1.53M | - | $1.53M | 100% |
Motus GI Holdings Inc. (MOTS) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Motus GI Holdings Inc. ever had a stock split?
Motus GI Holdings Inc. Profile
| Health Care Technology Industry | Healthcare Sector | Ravit Ram CEO | NASDAQ (CM) Exchange | 62014P108 CUSIP |
| US Country | 15 Employees | - Last Dividend | 2 Nov 2023 Last Split | 14 Feb 2018 IPO Date |
Overview
Motus GI Holdings, Inc., a pioneering medical technology company based in the United States, specifically in Fort Lauderdale, Florida, has made notable strides in the medical field since its inception in 2008. Initially founded as Eight-Ten Merger Corp., the company underwent a significant rebranding in November 2016, adopting its current name, Motus GI Holdings, Inc. The company’s mission is to innovate and provide solutions that significantly improve gastrointestinal healthcare, focusing on enhancing the efficiency and effectiveness of colonoscopy and upper gastrointestinal endoscopy procedures.
Products and Services
- Pure-Vu System - A cutting-edge medical device designed to significantly improve the cleanliness of the gastrointestinal tract during colonoscopy procedures.
The Pure-Vu System addresses a common challenge in colonoscopy procedures: the thorough cleansing of a poorly prepared gastrointestinal tract. By facilitating a more effective cleaning process, this system aims to improve the procedural efficiency and accuracy, potentially leading to better patient outcomes and a reduction in the need for repeat procedures.
- Upper Gastrointestinal Endoscopy Facilitation - Extends the company's technological innovation to upper gastrointestinal endoscopy procedures.
While the Pure-Vu System is primarily recognized for its application in colonoscopy procedures, Motus GI Holdings, Inc. has also adapted its technology to facilitate upper gastrointestinal endoscopy procedures. This application of the Pure-Vu technology aims to improve visualization and treatment within the upper gastrointestinal tract, underscoring the company’s commitment to broadening the scope of its medical solutions to enhance patient care across a range of gastrointestinal challenges.
